Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

HEPAHepion Pharmaceuticals, Inc.

OTC · CIK 0001583771
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts324

Identity from submissions API

NameHepion Pharmaceuticals, Inc.
CIK0001583771
TickersHEPA, CTRVP
ExchangesOTC, OTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN462783806
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone732-902-4000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ContraVir Pharmaceuticals, Inc. (2013-08-08T04:00:00.000Z → 2019-07-23T04:00:00.000Z)
Business address
34 SHREWSBURY AVE.
SUITE 1D
RED BANK
NJ
07701
NJ
Mailing address
34 SHREWSBURY AVE.
SUITE 1D
RED BANK
NJ
07701
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

725 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 10-Q/A 10-Q/A 0001493152-26-052735 001-36856 261564216 34 6058560 1 1
2026-11-16 10-Q 10-Q 0001493152-26-052407 001-36856 261561208 34 5888568 1 1
2026-10-27 4 4 0001493152-26-048710 5575
2026-10-27 4 4 0001493152-26-048709 5549
2026-10-27 4 4 0001493152-26-048708 5552
2026-10-27 4 4 0001493152-26-048707 5618
2026-10-27 4 4 0001493152-26-048706 5540
2026-10-27 4 4 0001493152-26-048705 5599
2026-10-27 4 4 0001493152-26-048704 5599
2026-10-27 4 4 0001493152-26-048703 5560
2026-10-26 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-048601 005-87637 261487071 34 7835
2026-10-21 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-047920 005-87637 261476517 34 6667
2026-10-21 3 3 0001493152-26-047910 4031
2026-10-14 S-8 S-8 0001493152-26-047024 333-299454 261460119 33 257144 1 1
2026-10-09 8-K 8-K 1.01,2.01,3.02,5.02,9.01 0001493152-26-046546 001-36856 261453244 34 973169 1 1
2026-10-02 4 4 0001493152-26-045526 6939
2026-10-02 8-K 8-K 5.03,9.01 0001493152-26-045447 001-36856 261433705 34 211957 1 1
2026-09-28 8-K 8-K 4.01,9.01 0001493152-26-044432 001-36856 261411931 34 212225 1 1
2026-09-16 3 3 0001493152-26-042909 5527
2026-09-16 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-042907 005-87637 261383898 34 9400
2026-09-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-042788 005-87637 261381856 34 6701
2026-09-14 4 4 0001493152-26-042470 6072
2026-09-10 DEF 14C DEF 14C 0001493152-26-042187 001-36856 261371476 34 388503
2026-09-10 4 4 0001493152-26-042169 5461
2026-09-08 8-K 8-K 1.01,2.03,3.02,9.01 0001493152-26-041801 001-36856 261365956 34 945502 1 1
2026-08-31 PRE 14C PRE 14C 0001493152-26-040669 001-36856 261341791 34 709270 1 1
2026-08-27 8-K 8-K 1.01,3.02,9.01 0001493152-26-040411 001-36856 261331049 34 208587 1 1
2026-08-21 4 4 0001493152-26-039705 5630
2026-08-21 4 4 0001493152-26-039702 5705
2026-08-21 4 4 0001493152-26-039701 5693
2026-08-21 4 4 0001493152-26-039698 5410
2026-08-21 4 4 0001493152-26-039690 5436
2026-08-21 4 4 0001493152-26-039688 5690
2026-08-21 4 4 0001493152-26-039685 5420
2026-08-21 3 3 0001493152-26-039550 3229
2026-08-20 8-K 8-K 5.02 0001493152-26-039488 001-36856 261300542 34 196758 1 1
2026-08-20 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-039484 005-87637 261300313 34 14041
2026-08-20 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-039483 005-87637 261300312 34 8917
2026-08-20 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-039482 005-87637 261300309 34 8818
2026-08-13 10-Q 10-Q 0001493152-26-037562 001-36856 261269951 34 19507301 1 1
2026-08-12 4 4 0001493152-26-037500 6944
2026-08-12 4 4 0001493152-26-037496 6929
2026-08-12 4 4 0001493152-26-037493 6995
2026-08-12 4 4 0001493152-26-037490 6989
2026-08-12 4 4 0001493152-26-037489 11783
2026-08-07 3 3 0001493152-26-036644 5445
2026-08-07 S-8 S-8 0001493152-26-036604 333-298130 261254766 33 248207 1 1
2026-08-07 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0002146838-26-000001 005-87637 261253279 34 14123
2026-08-05 D xslFormDX01/primary_doc.xml 06b 0001493152-26-036216 021-593256 261244892 33 11592
2026-08-04 8-K 8-K 1.01,3.02,9.01 0001493152-26-035940 001-36856 261235950 34 593430 1 1
2026-07-10 3 3 0001493152-26-032890 3216
2026-07-08 3 3 0001493152-26-032515 3206
2026-07-02 8-K 8-K 5.02 0001493152-26-031918 001-36856 261151874 34 198097 1 1
2026-06-17 8-K 8-K 5.07 0001493152-26-029085 001-36856 261098621 34 206194 1 1
2026-05-26 3 3 0001493152-26-025265 3892
2026-05-14 10-Q 10-Q 0001493152-26-023136 001-36856 26979720 34 4378911 1 1
2026-05-01 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-020941 005-87637 26933915 34 25564
2026-04-28 ARS ARS 0001493152-26-019388 001-36856 26909175 34 1019385
2026-04-28 DEFA14A DEFA14A 0001493152-26-019385 001-36856 26909087 34 1215742
2026-04-28 DEF 14A DEF 14A 0001493152-26-019382 001-36856 26909021 34 504200
2026-04-27 4 4 0001493152-26-019202 4861
2026-04-27 4 4 0001493152-26-019029 7169
2026-04-27 4 4 0001493152-26-019028 4832
2026-04-27 4 4 0001493152-26-019027 5083
2026-04-22 D xslFormDX01/primary_doc.xml 06b 0001493152-26-018593 021-581512 26884804 33 9896
2026-04-22 8-K 8-K 1.01,3.02,9.01 0001493152-26-018575 001-36856 26884459 34 455963 1 1
2026-04-14 8-K 8-K 1.01,5.02 0001493152-26-016557 001-36856 26861153 34 245710 1 1
2026-03-18 3 3 0001493152-26-011307 3136
2026-03-18 3 3 0001493152-26-011304 3202
2026-03-18 3 xslF345X06/ownership.xml 0001493152-26-011302 3146
2026-03-18 8-K 8-K 5.02 0001493152-26-011222 001-36856 26769159 34 243933 1 1
2026-03-12 10-K 10-K 0001493152-26-009755 001-36856 26745468 34 7197709 1 1
2026-03-03 8-K 8-K 1.01,8.01,9.01 0001493152-26-008650 001-36856 26711107 34 250006 1 1
2026-01-15 8-K 8-K 5.02 0001493152-26-002428 001-36856 26536446 34 206145 1 1
2025-11-12 10-Q 10-Q 0001493152-25-021864 001-36856 251471877 34 5327435 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-109202 005-87637 251222233 34 15860
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001303 005-87637 251221719 34 7415
2025-08-14 10-Q 10-Q 0001641172-25-023944 001-36856 251218144 34 5711095 1 1
2025-07-22 25-NSE xslF25X02/primary_doc.xml 0001354457-25-000728 001-36856 34 4328
2025-06-30 8-K 8-K 5.02 0001641172-25-017037 001-36856 251088695 34 199164 1 1
2025-06-12 8-K 8-K 5.07 0001641172-25-014858 001-36856 251043152 34 216994 1 1
2025-06-09 8-K 8-K 5.02 0001641172-25-014320 001-36856 251034514 34 199578 1 1
2025-05-30 8-K 8-K 1.01 0001641172-25-013048 001-36856 251011443 34 203139 1 1
2025-05-19 10-Q 10-Q 0001641172-25-011534 001-36856 25965219 34 4897259 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072865 005-87637 25955907 34 155920
2025-05-15 NT 10-Q NT 10-Q 0001641172-25-010988 001-36856 25954110 34 30956
2025-05-12 8-K 8-K 3.01,9.01 0001641172-25-009744 001-36856 25935814 34 238542 1 1
2025-05-06 8-K 8-K 1.01,3.02 0001641172-25-008761 001-36856 25915567 34 210872 1 1
2025-04-29 ARS formars.pdf 0001641172-25-006552 001-36856 25882488 34 1105706
2025-04-28 DEF 14A formdef14a.htm 0001641172-25-006440 001-36856 25881336 34 379142
2025-04-24 UPLOAD filename1.pdf 0000000000-25-004349 001-36856 39847
2025-04-23 PRER14A formprer14a.htm 0001641172-25-005837 001-36856 25861424 34 379897
2025-04-17 8-K form8-k.htm 3.01 0001641172-25-005241 001-36856 25847717 34 208309 1 1
2025-04-16 PRE 14A formpre14a.htm 0001641172-25-005060 001-36856 25845913 34 379472
2025-04-08 10-K form10-k.htm 0001641172-25-003250 001-36856 25822692 34 7738699 1 1
2025-04-04 8-K/A form8-ka.htm 8.01,9.01 0001641172-25-002775 001-36856 25815169 34 234201 1 1
2025-04-01 NT 10-K formnt10-k.htm 0001641172-25-001934 001-36856 25796057 34 31439
2025-03-20 8-K form8-k.htm 3.01 0001493152-25-011038 001-36856 25756916 34 210450 1 1
2025-03-19 8-K form8-k.htm 3.03,5.03,9.01 0001493152-25-010921 001-36856 25752937 34 5925305 1 1
2025-03-10 8-K form8-k.htm 5.07 0001493152-25-009686 001-36856 25723664 34 275781 1 1
2025-03-04 8-K form8-k.htm 8.01,9.01 0001493152-25-009075 001-36856 25706679 34 223283 1 1
2025-02-07 DEF 14A formdef14a.htm 0001493152-25-005322 001-36856 25599707 34 408201
2025-02-07 ARS/A formarsa.pdf 0001493152-25-005320 001-36856 25599697 34 361170
2025-02-07 ARS formars.pdf 0001493152-25-005316 001-36856 25599643 34 1172627
2025-01-27 PRE 14A formpre14a.htm 0001493152-25-003809 001-36856 25559487 34 408170
2025-01-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-000135 005-87637 25559200 34 7994
2025-01-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000147 005-87637 25555534 34 17619
2025-01-23 424B4 form424b4.htm 0001493152-25-003271 333-284052 25547517 33 449725
2025-01-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000152 333-284052 25543754 33 1878
2025-01-21 S-1MEF forms-1mef.htm 0001493152-25-003130 333-284398 25543741 33 132936
2025-01-17 CORRESP filename1.htm 0001493152-25-002689 11644
2025-01-17 CORRESP filename1.htm 0001493152-25-002688 12110
2025-01-15 CORRESP filename1.htm 0001493152-25-002404 12643
2025-01-15 CORRESP filename1.htm 0001493152-25-002402 7057
2025-01-15 8-K form8-k.htm 3.01 0001493152-25-002377 001-36856 25533075 34 210969 1 1
2025-01-14 CORRESP filename1.htm 0001493152-25-002058 12343
2025-01-14 CORRESP filename1.htm 0001493152-25-002056 12288
2025-01-14 S-1/A forms-1a.htm 0001493152-25-002041 333-284052 25527908 33 1584657
2025-01-13 10-K/A form10-ka.htm 0001493152-25-001857 001-36856 25524734 34 532621 1 1
2025-01-02 UPLOAD filename1.pdf 0000000000-25-000003 333-284052 40263
2024-12-26 S-1 forms-1.htm 0001493152-24-052155 333-284052 241581781 33 490395
2024-12-11 8-K form8-k.htm 1.02,8.01,9.01 0001493152-24-049561 001-36856 241540247 34 261057 1 1
2024-12-05 DEFA14A formdefa14a.htm 0001493152-24-048813 001-36856 241527955 34 83447
2024-12-02 DEFA14A formdefa14a.htm 0001493152-24-048238 001-36856 241517524 34 53352
2024-11-21 425 form425.htm 0001493152-24-047183 001-36856 241485295 34 30524
2024-11-21 8-K form8-k.htm 3.01 0001493152-24-047182 001-36856 241485290 34 215359 1 1
2024-11-14 10-Q form10-q.htm 0001493152-24-046002 001-36856 241463769 34 5943591 1 1
2024-11-14 SC 13G/A armistice-hepa093024a1.htm 0001172661-24-005180 005-87637 241462079 34 90727
2024-09-05 425 form425.htm 0001493152-24-035080 001-36856 241279891 34 31182
2024-09-05 8-K form8-k.htm 3.01 0001493152-24-035076 001-36856 241279777 34 216214 1 1
2024-08-13 10-Q form10-q.htm 0001493152-24-031582 001-36856 241201151 34 6228176 1 1
2024-08-07 425 form425.htm 0001493152-24-030498 001-36856 241181777 34 29499
2024-08-07 8-K form8-k.htm 5.02 0001493152-24-030495 001-36856 241181769 34 210163 1 1
2024-07-24 D xslFormDX01/primary_doc.xml 06b 0001493152-24-028850 021-519570 241135746 33 11564
2024-07-22 425 form425.htm 0001493152-24-028640 001-36856 241129616 34 11584297
2024-07-22 8-K form8-k.htm 1.01,2.03,3.02,5.02,7.01,8.01,9.01 0001493152-24-028637 001-36856 241129575 34 12058216 1 1
2024-07-15 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-07-15 16:30:00 9999999995-24-002169 333-280752 241118526 33 1879
2024-07-15 424B3 form424b3.htm 0001493152-24-027889 333-280752 241118042 33 408155
2024-07-12 CORRESP filename1.htm 0001493152-24-027151 12307
2024-07-12 UPLOAD filename1.pdf 0000000000-24-007969 333-280752 40171
2024-07-11 S-1 forms-1.htm 0001493152-24-026896 333-280752 241111193 33 588302
2024-06-25 10-K/A form10-ka.htm 0001493152-24-025007 001-36856 241065843 34 528203 1 1
2024-05-21 10-Q 10-Q 0001628280-24-024560 001-36856 24970579 34 5392300 1 1
2024-05-15 NT 10-Q formnt10-q.htm 0001493152-24-019950 001-36856 24952079 34 29851
2024-04-16 10-K 10-K 0001583771-24-000003 001-36856 24848486 34 6894989 1 1
2024-04-01 NT 10-K NT 10-K 0001104659-24-041880 001-36856 24809857 34 19405
2024-03-07 4 xslF345X05/ownership.xml 0001493152-24-009215 5674
2024-03-06 3 xslF345X02/ownership.xml 0001493152-24-009040 3119
2024-03-06 8-K form8-k.htm 5.02 0001493152-24-009028 001-36856 24726055 34 208410 1 1
2024-02-21 4 xslF345X05/ownership.xml 0001493152-24-007465 5309
2024-02-21 4 xslF345X05/ownership.xml 0001493152-24-007462 5143
2024-02-21 4 xslF345X05/ownership.xml 0001493152-24-007464 5274
2024-02-21 4 xslF345X05/ownership.xml 0001493152-24-007463 5325
2024-02-20 8-K form8-k.htm 5.02 0001493152-24-007222 001-36856 24653485 34 207844 1 1
2024-02-16 8-K FORM 8-K 1.01,3.02,9.01 0001104659-24-024738 001-36856 24645910 34 592228 1 1
2024-02-14 SC 13G armistice-hepa123123.htm 0001172661-24-001361 005-87637 24636986 34 90668
2024-02-07 8-K FORM 8-K 5.02 0001104659-24-011616 001-36856 24604485 34 196804 1 1
2024-01-03 8-K FORM 8-K 4.01,9.01 0001104659-24-000860 001-36856 24507014 34 213243 1 1
2023-12-07 8-K FORM 8-K 5.02,8.01,9.01 0001104659-23-124182 001-36856 231471152 34 219630 1 1
2023-11-28 4 OWNERSHIP DOCUMENT 0001104659-23-121427 6051
2023-11-20 10-Q 10-Q 0001583771-23-000013 001-36856 231422683 34 5143774 1 1
2023-11-14 NT 10-Q NT 10-Q 0001104659-23-118189 001-36856 231407414 34 20731
2023-11-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-08 16:00:00 9999999995-23-003254 333-275231 231389787 33 1830
2023-11-06 CORRESP filename1.htm 0001104659-23-114484 7153
2023-11-03 UPLOAD filename1.pdf 0000000000-23-012074 40389
2023-10-31 S-1 FORM S-1 0001104659-23-112946 333-275231 231364719 33 265063
2023-10-03 D xslFormDX01/primary_doc.xml 06b 0001104659-23-106467 021-493729 231305489 33 12385
2023-10-03 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-23-106030 001-36856 231301025 34 908944 1 1
2023-10-02 424B5 424B5 0001104659-23-105939 333-254996 231300411 33 573554
2023-09-20 4 OWNERSHIP DOCUMENT 0001104659-23-102209 9003
2023-09-19 4 OWNERSHIP DOCUMENT 0001104659-23-101784 4654
2023-09-18 4 OWNERSHIP DOCUMENT 0001104659-23-101391 4658
2023-09-06 8-K FORM 8-K 5.02 0001104659-23-098668 001-36856 231239740 34 196155 1 1
2023-08-14 10-Q 10-Q 0001583771-23-000010 001-36856 231170244 34 4512668 1 1
2023-07-24 8-K FORM 8-K 7.01,9.01 0001104659-23-083425 001-36856 231105082 34 6369271 1 1
2023-07-21 8-K FORM 8-K 1.01,9.01 0001104659-23-083084 001-36856 231102963 34 577396 1 1
2023-07-21 424B5 424B5 0001104659-23-083083 333-254996 231102953 33 628635
2023-07-14 S-8 S-8 0001104659-23-081294 333-273269 231089771 33 92712
2023-06-22 8-K FORM 8-K 5.07 0001104659-23-073836 001-36856 231034194 34 209738 1 1
2023-05-22 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-063036 001-36856 23943447 34 6937355 1 1
2023-05-12 10-Q 10-Q 0001583771-23-000007 001-36856 23916039 34 4733630 1 1
2023-05-10 8-K FORM 8-K 5.03,8.01,9.01 0001104659-23-058529 001-36856 23907717 34 229293 1 1
2023-04-28 ARS ARS 0001104659-23-053119 001-36856 23867605 34 1422826
2023-04-28 DEFA14A DEFA14A 0001104659-23-053114 001-36856 23867487 34 483337
2023-04-28 DEF 14A DEF 14A 0001104659-23-053093 001-36856 23867316 34 576124
2023-04-10 10-K 10-K 0001583771-23-000003 001-36856 23811615 34 6940749 1 1
2023-04-03 NT 10-K FORM NT 10-K 0001104659-23-040338 001-36856 23789614 34 19710
2022-12-16 8-K FORM 8-K 5.07 0001104659-22-127475 001-36856 221466257 34 197639 1 1
2022-11-21 DEF 14A DEF 14A 0001104659-22-120839 001-36856 221406623 34 179426
2022-11-15 D xslFormDX01/primary_doc.xml 06b 0001104659-22-119135 021-464880 221391328 33 12662
2022-11-14 10-Q 10-Q 0001583771-22-000012 001-36856 221385726 34 5908527 1 1
2022-11-09 PRE 14A PRE 14A 0001104659-22-116575 001-36856 221373738 34 179943
2022-11-09 8-K FORM 8-K 1.01,3.02,3.03,5.03,8.01,9.01 0001104659-22-116082 001-36856 221370443 34 1215359 1 1
2022-10-17 8-K FORM 8-K 7.01,9.01 0001104659-22-109389 001-36856 221314294 34 6877033 1 1
2022-08-15 10-Q 10-Q 0001583771-22-000009 001-36856 221166560 34 5612040 1 1
2022-08-05 8-K FORM 8-K 5.07 0001104659-22-086685 001-36856 221140778 34 199590 1 1
2022-07-26 DEFA14A DEFA14A 0001104659-22-082770 001-36856 221107162 34 1001106
2022-07-25 DEFA14A DEFA14A 0001104659-22-082144 001-36856 221100876 34 351664
2022-07-20 3 OWNERSHIP DOCUMENT 0001104659-22-081043 4256
2022-07-05 3 OWNERSHIP DOCUMENT 0001104659-22-077086 4244
2022-06-30 DEFA14A DEFA14A 0001104659-22-075875 001-36856 221055904 34 23624
2022-06-28 8-K FORM 8-K 5.02,9.01 0001104659-22-075050 001-36856 221046871 34 222596 1 1
2022-06-27 8-K FORM 8-K 5.07 0001104659-22-074485 001-36856 221041512 34 218106 1 1
2022-06-24 DEFA14A DEFA14A 0001104659-22-074323 001-36856 221040415 34 20645
2022-06-14 DEFA14A DEFA14A 0001104659-22-071003 001-36856 221014734 34 44321
2022-06-06 8-K FORM 8-K 3.01 0001104659-22-068524 001-36856 22998259 34 201389 1 1
2022-05-31 DEFA14A DEFA14A 0001104659-22-066620 001-36856 22984190 34 25512
2022-05-27 8-K FORM 8-K 7.01,9.01 0001104659-22-065556 001-36856 22972729 34 6265046 1 1
2022-05-16 10-Q 10-Q 0001583771-22-000006 001-36856 22929416 34 5201643 1 1
2022-04-29 DEF 14A DEF 14A 0001104659-22-053818 001-36856 22877405 34 436675
2022-04-20 PRE 14A PRE 14A 0001104659-22-047942 001-36856 22839098 34 440639
2022-04-08 10-K 10-K 0001583771-22-000003 001-36856 22817984 34 7938132 1 1
2022-03-31 NT 10-K NT 10-K 0001104659-22-041111 001-36856 22793566 34 20683
2022-02-14 SC 13G/A AMENDMENT TO SC 13G 0001387131-22-001749 005-87637 22624443 34 78991
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-017735 005-87637 22609946 34 13094
2022-01-19 SC 13G/A HEPION PHARMACEUTICALS, INC. 0000902664-22-000338 005-87637 22537246 34 75808
2022-01-12 8-K FORM 8-K 5.02,9.01 0001104659-22-003432 001-36856 22525787 34 206731 1 1
2022-01-10 8-K FORM 8-K 7.01,9.01 0001104659-22-002406 001-36856 22519526 34 13300036 1 1
2022-01-06 8-K FORM 8-K 8.01,9.01 0001104659-22-001950 001-36856 22515625 34 211650 1 1
2022-01-04 SC 13G/A SABBY 13G-A HEPA 1.03.22 0001535610-22-000011 005-87637 22503294 34 13356
2021-12-21 8-K FORM 8-K 8.01,9.01 0001104659-21-151970 001-36856 211506911 34 217989 1 1
2021-11-30 8-K FORM 8-K 8.01,9.01 0001104659-21-144719 001-36856 211458337 34 213247 1 1
2021-11-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-11-24 16:00:00 9999999995-21-004474 333-254996 211449025 33 1830
2021-11-22 CORRESP filename1.htm 0001104659-21-142410 6606
2021-11-19 S-3/A S-3/A 0001104659-21-141964 333-254996 211429102 33 569619
2021-11-16 8-K FORM 8-K 8.01,9.01 0001104659-21-139712 001-36856 211414228 34 220416 1 1
2021-11-15 10-Q 10-Q 0001583771-21-000011 001-36856 211411495 34 6555623 1 1
2021-11-10 8-K FORM 8-K 8.01,9.01 0001104659-21-136715 001-36856 211394782 34 234046 1 1
2021-10-08 8-K FORM 8-K 5.07 0001104659-21-124637 001-36856 211315616 34 215911 1 1
2021-10-07 8-K FORM 8-K 8.01,9.01 0001104659-21-124189 001-36856 211312638 34 211377 1 1
2021-09-30 8-K FORM 8-K 7.01,9.01 0001104659-21-121315 001-36856 211295907 34 3002255 1 1
2021-09-29 8-K FORM 8-K 8.01,9.01 0001104659-21-120515 001-36856 211289611 34 216951 1 1
2021-09-13 8-K FORM 8-K 7.01,9.01 0001104659-21-114896 001-36856 211248702 34 9078290 1 1
2021-09-07 DEF 14A DEF 14A 0001104659-21-113008 001-36856 211237582 34 449752
2021-08-23 8-K FORM 8-K 5.03,9.01 0001104659-21-108392 001-36856 211195512 34 209176 1 1
2021-08-23 PRE 14A PRE 14A 0001104659-21-108294 001-36856 211195284 34 452941
2021-08-16 10-Q 10-Q 0001583771-21-000008 001-36856 211178508 34 5914653 1 1
2021-07-26 8-K FORM 8-K 8.01,9.01 0001104659-21-095513 001-36856 211111858 34 210966 1 1
2021-07-13 8-K FORM 8-K 8.01,9.01 0001104659-21-091511 001-36856 211087038 34 228773 1 1
2021-06-25 DEFA14A DEFA14A 0001104659-21-085780 001-36856 211048615 34 29673
2021-06-25 8-K FORM 8-K 8.01,9.01 0001104659-21-085776 001-36856 211048597 34 213656 1 1
2021-06-09 8-K FORM 8-K 8.01,9.01 0001104659-21-078565 001-36856 211004095 34 29389
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-070074 5480
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069942 5446
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069940 5342
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069939 5678
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069938 5668
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069936 5517
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069935 5513
2021-05-20 4 OWNERSHIP DOCUMENT 0001104659-21-069934 5352
2021-05-14 10-Q 10-Q 0001583771-21-000004 001-36856 21925626 34 5584014 1 1
2021-05-12 DEF 14A DEF 14A 0001104659-21-064731 001-36856 21913165 34 322798
2021-05-06 8-K FORM 8-K 8.01,9.01 0001104659-21-062141 001-36856 21896267 34 26889
2021-04-29 8-K FORM 8-K 8.01,9.01 0001104659-21-057102 001-36856 21867658 34 27673
2021-04-28 PRE 14A PRE 14A 0001104659-21-056643 001-36856 21865500 34 324536
2021-04-28 10-K/A FORM 10-K/A 0001104659-21-056641 001-36856 21865488 34 235209
2021-04-07 UPLOAD filename1.pdf 0000000000-21-004206 40330
2021-04-02 S-3 FORM S-3 0001104659-21-046023 333-254996 21801669 33 1101717
2021-03-31 10-K 10-K 0001558370-21-003836 001-36856 21794272 34 7911222 1
2021-03-23 8-K FORM 8-K 8.01,9.01 0001104659-21-040040 001-36856 21763218 34 52178
2021-03-11 8-K FORM 8-K 8.01,9.01 0001104659-21-034773 001-36856 21731948 34 31057
2021-02-24 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-21-002768 005-87637 21669699 34 82170
2021-02-19 SC 13G SABBY 13G HEPA 2.19.21 0001535610-21-000079 005-87637 21654654 34 13421
2021-02-18 4 OWNERSHIP DOCUMENT 0001104659-21-025200 4542
2021-02-18 4 OWNERSHIP DOCUMENT 0001104659-21-025199 4621
2021-02-18 4 OWNERSHIP DOCUMENT 0001104659-21-025196 4616
2021-02-18 SC 13G HEPION PHARMACEUTICALS, INC. 0000902664-21-001479 005-87637 21648186 34 82609
2021-02-17 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-21-024672 001-36856 21642697 34 477387
2021-02-16 424B5 424B5 0001104659-21-024370 333-229534 21640740 33 530203
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023232 005-87637 21633708 34 65015
2021-02-16 424B5 424B5 0001104659-21-022382 333-229534 21631731 33 532624
2021-02-12 FWP FWP 0001104659-21-022167 333-229534 21629965 34 2798425
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-018267 005-87637 21610990 34 13935
2021-02-10 8-K FORM 8-K 8.01,9.01 0001104659-21-017112 001-36856 21609491 34 35394
2021-02-09 SC 13G/A HEPA 13GA 0001393825-21-000039 005-87637 21606216 34 55935
2021-01-28 8-K FORM 8-K 7.01,9.01 0001104659-21-008805 001-36856 21565536 34 5121421
2021-01-20 SC 13G/A HEPION PHARMACEUTICALS, INC. 0000902664-21-000334 005-87637 21537751 34 82734
2021-01-19 S-8 S-8 0001104659-21-004877 333-252188 21533585 33 241030
2021-01-07 SC 13G/A SABBY 13G-A HEPA 1.07.21 0001535610-21-000061 005-87637 21513788 34 13356
2021-01-05 8-K FORM 8-K 8.01,9.01 0001104659-21-000667 001-36856 21504138 34 25012
2020-12-29 8-K FORM 8-K 8.01,9.01 0001104659-20-140161 001-36856 201422642 34 45355
2020-12-28 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-011825 005-87637 201418972 34 60527
2020-12-22 8-K FORM 8-K 8.01,9.01 0001104659-20-138364 001-36856 201406118 34 32860
2020-12-21 4 OWNERSHIP DOCUMENT 0001104659-20-137755 4540
2020-12-10 8-K FORM 8-K 8.01,9.01 0001104659-20-134049 001-36856 201379910 34 28325
2020-12-09 SC 13G SCHEDULE 13G 0001387131-20-010634 005-87637 201376861 34 61352
2020-12-08 4 OWNERSHIP DOCUMENT 0001104659-20-133141 4625
2020-12-02 4 4 0001104659-20-131656 4492
2020-12-02 SC 13G HEPION PHARMACEUTICALS, INC. 0000902664-20-004112 005-87637 201362758 34 82395
2020-12-02 8-K FORM 8-K 8.01,9.01 0001104659-20-131336 001-36856 201362433 34 32166
2020-12-02 SC 13G SABBY 13G HEPA 12.01.20 0001535610-20-000122 005-87637 201362207 34 13394
2020-12-01 4 4 0001104659-20-131213 4319
2020-11-30 4 4 0001104659-20-130531 4537
2020-11-27 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-129940 001-36856 201354512 34 414354
2020-11-25 424B4 424B4 0001104659-20-129525 333-249724 201350963 33 1192045
2020-11-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-11-24 17:20:00 9999999995-20-003300 333-249724 201346736 33 1830
2020-11-20 CORRESP filename1.htm 0001104659-20-128057 16222
2020-11-20 CORRESP filename1.htm 0001104659-20-128055 6394
2020-11-20 S-1/A S-1/A 0001104659-20-128053 333-249724 201333549 33 1845544
2020-11-20 8-K FORM 8-K 1.02 0001104659-20-127940 001-36856 201332490 34 17112
2020-11-18 FWP FWP 0001104659-20-126940 333-249724 201326096 34 2989348
2020-11-18 S-1/A S-1/A 0001104659-20-126937 333-249724 201326094 33 3477429
2020-11-18 8-K FORM 8-K 8.01,9.01 0001104659-20-126644 001-36856 201323113 34 29148
2020-11-17 8-K FORM 8-K 8.01,9.01 0001104659-20-126394 001-36856 201321775 34 23116
2020-11-16 10-Q 10-Q 0001558370-20-013898 001-36856 201318125 34 7339424 1
2020-11-12 FWP FWP 0001104659-20-124498 333-249724 201308135 34 3065188
2020-11-12 S-1/A S-1/A 0001104659-20-124495 333-249724 201308122 33 3875897
2020-11-12 8-K FORM 8-K 8.01,9.01 0001104659-20-124080 001-36856 201303961 34 27796
2020-11-10 8-K FORM 8-K 8.01,9.01 0001104659-20-123409 001-36856 201300014 34 27491
2020-11-05 UPLOAD filename1.pdf 0000000000-20-010571 40312
2020-10-29 S-1 FORM S-1 0001104659-20-119514 333-249724 201272652 33 1592161
2020-10-27 8-K FORM 8-K 8.01,9.01 0001104659-20-118410 001-36856 201262418 34 28972
2020-10-05 8-K FORM 8-K 8.01,9.01 0001104659-20-112001 001-36856 201222439 34 32475
2020-10-01 8-K FORM 8-K 7.01,9.01 0001104659-20-111073 001-36856 201216276 34 2299605
2020-09-29 8-K FORM 8-K 8.01,9.01 0001104659-20-109531 001-36856 201206546 34 22495
2020-09-17 8-K FORM 8K 8.01,9.01 0001104659-20-106030 001-36856 201180627 34 28405
2020-09-01 8-K FORM 8-K 8.01,9.01 0001104659-20-101285 001-36856 201153970 34 26937
2020-08-27 8-K FORM 8-K 8.01,9.01 0001104659-20-099208 001-36856 201140420 34 27705
2020-08-21 4 4 0001104659-20-097602 5358
2020-08-21 4 4 0001104659-20-097600 5086
2020-08-21 4 4 0001104659-20-097599 5119
2020-08-21 4 4 0001104659-20-097598 4958
2020-08-21 4 4 0001104659-20-097596 5123
2020-08-21 4 4 0001104659-20-097593 4948
2020-08-21 4 4 0001104659-20-097592 5052
2020-08-21 4 4 0001104659-20-097591 5349
2020-08-12 10-Q 10-Q 0001558370-20-010449 001-36856 201096302 34 6128277 1
2020-08-12 8-K FORM 8-K 8.01,9.01 0001104659-20-093579 001-36856 201094250 34 32350
2020-08-05 8-K FORM 8-K 8.01,9.01 0001104659-20-090611 001-36856 201075905 34 33411
2020-07-30 8-K FORM 8-K 5.07 0001104659-20-088432 001-36856 201062134 34 25444
2020-07-07 8-K FORM 8-K 8.01,9.01 0001104659-20-081577 001-36856 201015281 34 39348
2020-06-29 10-Q 10-Q 0001558370-20-007863 001-36856 20998820 34 5320062 1
2020-06-29 8-K FORM 8-K 8.01,9.01 0001104659-20-078110 001-36856 20998652 34 28670
2020-06-25 4 4 0001104659-20-076967 5182
2020-06-25 3 3 0001104659-20-076747 2894
2020-06-22 8-K FORM 8-K 8.01,9.01 0001104659-20-075664 001-36856 20979389 34 29797
2020-06-15 10-K/A FORM 10-K/A 0001104659-20-073279 001-36856 20962283 34 116547
2020-06-15 8-K FORM 8-K 7.01,9.01 0001104659-20-073220 001-36856 20962073 34 7812936
2020-06-12 DEF 14A DEF 14A 0001104659-20-072949 001-36856 20960774 34 253254
2020-06-10 8-K FORM 8-K 5.02,9.01 0001104659-20-072061 001-36856 20955392 34 30185
2020-05-20 8-K FORM 8-K 8.01,9.01 0001104659-20-064298 001-36856 20898596 34 25518
2020-05-20 8-K FORM 8-K 7.01,9.01 0001104659-20-063929 001-36856 20895608 34 6290527
2020-05-19 8-K FORM 8-K 8.01,9.01 0001104659-20-063482 001-36856 20891611 34 31119
2020-05-14 8-K FORM 8-K 8.01 0001104659-20-061607 001-36856 20877937 34 23995
2020-05-14 10-K FORM 10-K 0001104659-20-061587 001-36856 20877756 34 8031004 1
2020-04-17 8-K FORM 8-K 1.01,2.03 0001104659-20-048184 001-36856 20799715 34 17590
2020-04-07 4 4 0001104659-20-044175 4956
2020-04-07 4 4 0001104659-20-044174 5118
2020-04-07 4 4 0001104659-20-044173 5085
2020-04-07 4 4 0001104659-20-044171 5122
2020-04-07 4 4 0001104659-20-044170 5348
2020-04-07 4 4 0001104659-20-044169 4947
2020-04-07 4 4 0001104659-20-044168 5347
2020-03-30 8-K FORM 8-K 8.01 0001104659-20-040351 001-36856 20756983 34 23057
2020-03-27 8-K FORM 8-K 8.01,9.01 0001104659-20-039453 001-36856 20749804 34 32356
2020-03-27 424B5 424B5 0001104659-20-039007 333-229534 20747706 33 568656
2020-03-12 8-K FORM 8-K 8.01,9.01 0001104659-20-032197 001-36856 20707304 34 31074
2020-03-11 8-K FORM 8-K 7.01,9.01 0001104659-20-031925 001-36856 20705277 34 5160448
2020-02-20 8-K FORM 8-K 8.01,9.01 0001104659-20-023108 001-36856 20632744 34 29469
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038287 005-87637 20620217 34 121847
2020-02-12 8-K FORM 8-K 1.01,9.01 0001104659-20-019329 001-36856 20605049 34 299688
2020-02-12 8-K FORM 8-K 8.01,9.01 0001104659-20-019281 001-36856 20604461 34 25069
2020-02-12 424B5 424B5 0001104659-20-018093 333-229534 20600294 33 561285
2020-02-10 SC 13G/A SC 13G/A 0001104659-20-013407 005-87637 20591611 34 88279
2020-02-07 8-K FORM 8-K 7.01,9.01 0001104659-20-012568 001-36856 20588084 34 2168192
2020-02-05 SC 13G HEPA 13G 0001393825-20-000049 005-87637 20578535 34 59281
2020-01-28 8-K FORM 8-K 8.01,9.01 0001104659-20-007676 001-36856 20554632 34 31198
2020-01-09 8-K FORM 8-K 8.01,9.01 0001104659-20-002344 001-36856 20516747 34 30213
2020-01-06 8-K FORM 8-K 8.01,9.01 0001104659-20-001530 001-36856 20509998 34 212644 1 1
2019-12-11 8-K FORM 8-K 8.01,9.01 0001104659-19-071787 001-36856 191279478 34 211553 1 1
2019-12-04 8-K FORM 8-K 8.01,9.01 0001104659-19-069650 001-36856 191267008 34 30364
2019-12-03 8-K FORM 8-K 7.01,8.01,9.01 0001104659-19-069534 001-36856 191265967 34 4214338
2019-11-21 8-K FORM 8-K 8.01,9.01 0001104659-19-065988 001-36856 191235568 34 28411
2019-11-14 10-Q 10-Q 0001104659-19-064342 001-36856 191221617 34 7242889 1
2019-11-08 8-K 8-K 8.01,9.01 0001104659-19-061252 001-36856 191201715 34 36508
2019-11-07 8-K 8-K 8.01,9.01 0001104659-19-060965 001-36856 191199350 34 35230
2019-10-23 8-K 8-K 8.01,9.01 0001104659-19-055831 001-36856 191164081 34 35732
2019-10-21 S-8 S-8 0001104659-19-055285 333-234278 191159781 33 108305
2019-10-16 8-K 8-K 8.01,9.01 0001104659-19-054409 001-36856 191153270 34 37995
2019-10-10 8-K 8-K 8.01,9.01 0001104659-19-053658 001-36856 191145700 34 35693
2019-10-08 8-K 8-K 5.02 0001104659-19-053382 001-36856 191142854 34 28195
2019-10-03 8-K 8-K 8.01,9.01 0001104659-19-052985 001-36856 191135945 34 37118
2019-09-04 8-K 8-K 8.01,9.01 0001104659-19-048627 001-36856 191073688 34 35529
2019-09-03 8-K 8-K 8.01,9.01 0001104659-19-048456 001-36856 191072482 34 38130
2019-08-14 10-Q 10-Q 0001104659-19-045967 001-36856 191027750 34 7054789 1
2019-08-14 8-K 8-K 9.01 0001104659-19-045808 001-36856 191023112 34 37237
2019-08-07 8-K 8-K 8.01,9.01 0001104659-19-044473 001-36856 191004734 34 36770
2019-07-31 8-K 8-K 8.01,9.01 0001104659-19-042855 001-36856 19988234 34 41997
2019-07-30 8-K 8-K 8.01,9.01 0001104659-19-042663 001-36856 19986108 34 37065
2019-07-25 4 4 0001104659-19-041851 5344
2019-07-25 4 4 0001104659-19-041850 4942
2019-07-25 4 4 0001104659-19-041849 5117
2019-07-25 4 4 0001104659-19-041847 5113
2019-07-25 4 4 0001104659-19-041845 4952
2019-07-25 4 4 0001104659-19-041844 5356
2019-07-25 4 4 0001104659-19-041843 5080
2019-07-23 8-K 8-K 5.03,8.01,9.01 0001104659-19-041380 001-36856 19966797 34 47161
2019-06-28 SC 13G SC 13G 0001193125-19-185110 005-87637 19927411 34 131241
2019-06-27 SC 13G SC 13G 0001104659-19-037772 005-87637 19923199 34 104564
2019-06-20 8-K 8-K 5.03,8.01,9.01 0001104659-19-036721 001-36856 19908871 34 152314

Latest XBRL company facts

One latest value per concept from companyfacts (324 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 125.07M 2026-11-08 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
dei EntityPublicFloat Entity Public Float USD 900,000 2025-06-30 2025 FY 10-K 2026-03-12 0001493152-26-009755
ffd NetFeeAmt NetFeeAmt USD 104.4 2026-10-14 S-8 2026-10-14 0001493152-26-047024
ffd TtlFeeAmt TtlFeeAmt USD 104.4 2026-10-14 S-8 2026-10-14 0001493152-26-047024
ffd TtlOfferingAmt TtlOfferingAmt USD 1.20M 2026-10-14 S-8 2026-10-14 0001493152-26-047024
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-14 S-8 2026-10-14 0001493152-26-047024
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 160,963 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 3.30M 2023-03-31 2023 Q1 10-Q 2023-05-12 0001583771-23-000007
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 127,263 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 635,155 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 117,992 2025-03-31 2025 Q1 10-Q 2025-05-19 0001641172-25-011534
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 420,732 2024-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD 100,000 2024-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 8,345 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 247.03M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 247.06M 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-023944
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 3.00M 2023-04-01 2023-04-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 245,637 2026-07-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 15,033 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-15 0001104659-14-039435
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD -1.04M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 204,191 2026-07-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -367,485 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-13 0001104659-16-120871
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-13 0001104659-16-120871
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 20,783 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 10,814 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 13,781 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-14 0001104659-19-045967
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 106.43M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 402,746 2025-01-01 2025-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap Assets Assets USD 5.01M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap AssetsCurrent Assets, Current USD 4.94M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 19,146 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 815,045 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -2.02M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 0 2024-06-30 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2024-06-30 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2024-06-30 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 10,410 2016-06-30 2017 FY 10-KT 2018-03-26 0001104659-18-019916
us-gaap Cash Cash USD 4.26M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 13.92M 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -1.15M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 4.26M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2.43M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2,380 2015-10-07 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 553,846 2025-01-23 2026 Q1 10-Q 2026-05-14 0001493152-26-023136
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 72.18M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 120.00M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 100.42M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 100.07M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap CommonStockValue Common Stock, Value, Issued USD 10,042 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -6.64M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 0 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap ContractualObligation Contractual Obligation USD 872,723 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 209,170 2018-12-31 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 202,734 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 194,529 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 209,170 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 2.10M 2024-03-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.44M 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1,206 2019-06-30 2019 Q2 10-Q 2019-08-14 0001104659-19-045967
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.97B 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2.97B 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 1.80M 2020-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 549,981 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 54,321 2019-01-01 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap DebtCurrent Debt, Current USD 299,582 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 176,585 2020-04-13 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 768,042 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 Debt Instrument, Convertible, Threshold Consecutive Trading Days Integer 10 2025-03-18 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 225,000 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 225,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 13,781 2018-06-30 2018 Q2 10-Q 2018-08-14 0001104659-18-052012
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 13,280 2019-03-31 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -536,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 62,486 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 9,235 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 113,212 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 45.49M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 62,486 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 26.32M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 1.98M 2018-12-31 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 5.85M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 4,430 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 64.90M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 45.49M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 360,700 2019-03-31 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap Depreciation Depreciation USD 100,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 30,758 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 7.87M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap DerivativeLiabilities Derivative Liability USD 8.90M 2023-10-03 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 7.87M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 9.80M 2014-03-31 2014 Q3 10-Q 2014-05-15 0001104659-14-039435
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap DividendsPreferredStockStock Dividends, Preferred Stock, Stock USD 3.14M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 6,928 2014-06-30 2015 FY 10-K 2015-09-25 0001104659-15-067379
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.18 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.1 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.18 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.783 2017-07-01 2017-12-31 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.036 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.105 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 87,124 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 466,593 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 371,712 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037562
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 0 2017-07-01 2017-09-30 2018 Q1 10-Q 2017-11-14 0001104659-17-068544
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 0 2017-07-01 2017-09-30 2018 Q1 10-Q 2017-11-14 0001104659-17-068544
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 3.09M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 0.28 2016-06-10 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.065 2016-06-10 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation USD 129,538 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -4,474 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -4,474 2018-01-01 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap Goodwill Goodwill USD 0 2022-12-31 2022 FY 10-K 2023-04-10 0001583771-23-000003
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 1.87M 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-28 0001104659-16-147194
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 402,746 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037562
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001583771-23-000013
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD -1.87M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-10 0001583771-23-000003
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 3.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -8.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -17.00M 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-28 0001104659-16-147194
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -1.35 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 1.00M 2019-04-01 2019-04-30 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -2.97M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 48,322 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 285,363 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -292,653 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 858,848 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -30,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 553,760 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 13,781 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-14 0001104659-18-052012
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 409,022 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -209,020 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD 117,452 2013-05-15 2014-03-31 2014 Q3 10-Q 2014-05-15 0001104659-14-039435
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD -9,235 2018-01-01 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 6,023 2016-07-01 2017-06-30 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 0 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease Indefinite-lived Intangible Assets, Period Increase (Decrease) USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001583771-23-000013
us-gaap InterestExpense Interest Expense USD 4,349 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap InterestExpenseDebt Interest Expense, Debt USD 555,441 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 12,945 2013-07-01 2014-06-30 2015 FY 10-K 2015-09-25 0001104659-15-067379
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 620 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 26,756 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 17,765 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 56,160 2016-07-01 2017-06-30 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 61,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 61,003 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 24,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 53,901 2019-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 53,902 2020-06-30 2020 Q2 10-Q 2020-08-12 0001558370-20-010449
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 16,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 24,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 6,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 8,997 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap Liabilities Liabilities USD 9.02M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.01M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.11M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2015-03-31 2015 Q3 10-Q 2015-05-14 0001104659-15-037966
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 176,585 2021-03-31 2021 Q1 10-Q 2021-05-14 0001583771-21-000004
us-gaap LongTermDebtPercentageBearingVariableInterestRate Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate pure 0.01 2020-04-13 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 1.39M 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-13 0001104659-16-120871
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.62M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 13.67M 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-04-12 0001104659-17-023119
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -500,000 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -12,284 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-04-12 0001104659-17-023119
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -14.92M 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-04-12 0001104659-17-023119
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -6.64M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -48.93M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -48.93M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -62,011 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap NotesPayable Notes Payable USD 0 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap NotesPayableCurrent Notes Payable, Current USD 296,623 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 100,328 2013-06-30 2014 FY 10-K 2014-09-29 0001047469-14-007919
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap NumberOfReportingUnits Number of Reporting Units segment 1 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap OperatingExpenses Operating Expenses USD 3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.56M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 99,914 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 70,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 18,953 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 42,050 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingLeasePayments Operating Lease, Payments USD 153,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 61,003 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 589,870 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 132,409 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 130,270 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 128,132 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 125,993 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 11,049 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 62,017 2014-12-31 2015 Q2 10-Q 2015-02-12 0001104659-15-009597
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.149 2023-08-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 131.20M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 136,180 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OtherAssets Other Assets USD 377,022 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 87,124 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 87,124 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 250,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023136
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 6,255 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 500,000 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap PaymentsForRent Payments for Rent USD 2,000 2026-09-03 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock Payments for Repurchase of Redeemable Convertible Preferred Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap PaymentsOfDerivativeIssuanceCosts Payments of Derivative Issuance Costs USD 500,000 2023-10-03 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 500,000 2023-10-03 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 76,380 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 495,603 2015-07-01 2016-06-30 2017 FY 10-KT 2018-03-26 0001104659-18-019916
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 132,117 2025-01-01 2025-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 14,304 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 600,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 5,816 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001583771-21-000011
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 1 2022-11-08 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 7.84M 2014-07-01 2015-06-30 2016 FY 10-K 2016-09-28 0001104659-16-147194
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2014-09-30 2015 Q1 10-Q 2014-11-13 0001104659-14-080146
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2014-09-30 2015 Q1 10-Q 2014-11-13 0001104659-14-080146
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2014-09-30 2015 Q1 10-Q 2014-11-13 0001104659-14-080146
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2014-09-30 2015 Q1 10-Q 2014-11-13 0001104659-14-080146
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.37M 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 187,445 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap PrepaidInsurance Prepaid Insurance USD 117,452 2014-03-31 2014 Q3 10-Q 2014-05-15 0001104659-14-039435
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 2.00M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4.26M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 176,585 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.23M 2013-07-01 2014-06-30 2015 FY 10-K 2015-09-25 0001104659-15-067379
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.00M 2023-10-03 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 5.00M 2023-10-03 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 490,000 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 250,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023136
us-gaap ProceedsFromPaymentsForLongTermLoansForRelatedParties Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties USD -500,000 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 350,000 2013-05-15 2013-12-31 2014 Q2 10-Q 2014-02-05 0001104659-14-006638
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 31,277 2016-07-01 2017-06-30 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 9.00M 2025-01-23 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease Property, Plant and Equipment, Gross, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 29,487 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 1.12M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.25M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-10 0001583771-23-000003
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 54,066 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 255,572 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 100,000 2024-03-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Employee 6 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap RestructuringCharges Restructuring Charges USD 700,000 2023-10-01 2023-12-31 2024 Q3 10-Q 2024-11-14 0001493152-24-046002
us-gaap RestructuringCosts Restructuring Costs USD 100,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 700,000 2023-12-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -252.74M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-21 0001628280-24-024560
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 60,499 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 553,846 2025-01-23 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 1,000 2018-07-03 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap SecurityDeposit Security Deposit USD 2,000 2026-09-03 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap SeveranceCosts1 Severance Costs USD 1.30M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 245,637 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 400,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-25 0001104659-15-067379
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001583771-21-000011
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 500,000 2023-04-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 110,000 2024-03-31 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 698,303 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 12.27 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 24 2019-01-01 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2024-04-01 2024-06-30 2024 Q2 10-Q 2024-08-13 0001493152-24-031582
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.37 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 266.00M 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 43,182 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 41,271 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 194.83 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 816,847 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 11.87 2018-09-30 2018 Q3 10-Q 2018-11-14 0001104659-18-068499
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 13,870 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021864
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 467.6 2019-01-01 2019-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap SharePrice Share Price USD/shares 0.43 2025-03-31 2025 Q1 10-Q 2025-05-19 0001641172-25-011534
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.1 2025-03-18 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap ShortTermBorrowings Short-term Debt USD 832,903 2019-03-31 2019 Q1 10-Q 2019-05-15 0001104659-19-029790
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 2.30M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023136
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -4.02M 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2023-05-03 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap StockIssued1 Stock Issued USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-16 0001583771-24-000003
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 1,353 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 8,929 2015-10-07 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 672,818 2025-04-01 2025-06-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 3.23M 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-29 0001047469-14-007919
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 296,037 2018-01-01 2018-12-31 2019 FY 10-K 2020-05-14 0001104659-20-061587
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 670,000 2026-04-01 2026-06-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 270,629 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 31,277 2016-07-01 2017-06-30 2018 FY 10-K 2019-03-14 0001104659-19-014652
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 21,799 2026-07-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 1.70M 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxLiabilityIncomeTaxBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit USD 373,000 2017-01-01 2017-12-31 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityExistingIncomeTaxBenefit Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Deferred Tax Liability, Existing Income Tax Benefit (Deprecated 2020-01-31) USD 536,000 2018-01-01 2018-03-31 2019 Q3 10-Q 2019-11-14 0001104659-19-064342
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 346,020 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap TreasuryStockValue Treasury Stock, Value USD 21,799 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 2.20M 2024-12-31 2024 FY 10-K 2025-04-08 0001641172-25-003250
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2021-12-31 2021 FY 10-K 2022-04-08 0001583771-22-000003
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 900,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001493152-26-009755
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 36.10M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 9.68M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001558370-21-003836
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 36.10M 2026-01-01 2026-09-30 2026 Q3 10-Q/A 2026-11-17 0001493152-26-052735

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →